Marco Londei

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text

Prevention of Arthritis by Interleukin 10–producing B Cells

Claudia Mauri, David Gray, Naseem Mushtaq et al. · The Journal of Experimental Medicine · 2003 · 839 citations · Full text

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

Luigi Maiuri, Carolina Ciacci, Ida Ricciardelli et al. · The Lancet · 2003 · 610 citations

Host Response, Allergy, Autoimmune Disease +12

DO CD4-POSITIVE CYTOTOXIC T CELLS DAMAGE ISLET β CELLS IN TYPE 1 DIABETES?

Piergiuseppe De Berardinis, Roger F.L. James, P. H. Wise et al. · The Lancet · 1988 · 468 citations

Autoimmune Disease, Diabetes, Immunology +10

Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells

Marco Londei, Jonathan R. Lamb, Gian Franco Bottazzo et al. · Nature · 1984 · 425 citations

Histocompatibility, Autoimmune Disease, Human T Cells +10